Listen to a curated selection ofNeurologyPodcasts on DEIcontent, chosenby Neurology DEISection Editor, Joshua A. Budhu, MD, MS.
Racial and Ethnic Differences in Antiseizure Medications Among People with Epilepsy on Medicaid
Dr. Halley Alexander talks with Dr. Wyatt Bensken about thedifference in antiseizure medications between racial and ethnic groups among people with epilepsy.Read the related article inNeurology: Clinical Practice.
Health Care Utilization in Functional Neurologic Disorders
Dr. Jon Stone talks with Dr. TjerkLagrandabout how the diagnosis of functional seizures affects health care costs.
Gender Disparities in the Career of Neurology Researchers
Dr. Holly Hinson talks with Dr. Deborah Hallabout gender disparities among neurology researchers. Read the full article in Neurology.
November Headache Series: CGRP and Role of Sex Hormones
Dr. Tesha Monteith talks with Dr. Lars Edvinsson who is a leading expert in the field of cerebral circulation and migraines. In this episode, they discuss CGRP and the role of sex hormones as part of our November Headache Series.
This podcast is sponsored by argenx. Visitwww.vyvgarthcp.comfor more information.
Young-Onset Ischemic Stroke Risk Factors in Black and White Individuals
Dr. B.J. Hicks talks with Dr. Prachi Mehndiratta about the differences in multiple risk factors between Black and White individuals with young-onset ischemic stroke. Read thefull article inNeurology.
This podcast is sponsored by argenx. Visitwww.vyvgarthcp.comfor more information.
Associations of Social Isolation and Loneliness in Dementia
Dr. Gregg Day talks with Prof. Barbara Sahakian about the associations of social isolation and loneliness with later dementia. Read thefull article inNeurology.
This podcast is sponsored by argenx. Visitwww.vyvgarthcp.comfor more information.
Antidepressant Use During Pregnancy and Seizure Risk in Children
Dr. Stacey Clardy talks with Kelsey Wiggs Karlan about whether children born to women who use serotonergic antidepressants during pregnancy have higher risk of neonatal seizures and epilepsy. Read thefull article inNeurology.
Medicare Limitation of Aduhelm
Dr. Jeff Burns talks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Research Center, about Medicare's recent decision to officially limit Aduhelm (aducanumab) coverage to patients in clinical trials. Read thefull article discussed in this interview in theNew York Times.
Race-Ethnic Disparities in Stroke Thrombolysis
Drs. B.J. Hicks and Andy Southerland talk with Dr. Scott Mendelson about racial and ethnic disparities in the rates of declination of thrombolysis in patients with acute ischemic stroke. Read thefull article inNeurology.
Availability of Lomustine for Glioblastoma Multiforme
Dr. Jeff Ratliff talks with Drs. Howard Colman and Kelly Fritz about the availability of lomustine for the treatment of glioblastoma multiforme (GBM) in light of the drug's recent withdrawal from Medicare Part D coverage.
Patient-Centered Treatment of Migraine with Medication Overuse
Dr. Tesha Monteith talks with Dr. Todd Schwedt about the treatment of chronic migraine with medication overuse through the patient-centered Medication Overuse Treatment Strategy (MOTS) clinical trial. Read the full article in Neurology.
April 2022 Neurology Recall: Physician as Patient
The April 2022 replay of past episodes showcases a selection of interviews with fellow neurologists about their personal experiences as patients. This episode features illuminating conversations with Drs. Daniel Drubach, Daniel Gibbs, Ted Burns, and Oliver Sacks, offering our listeners essential lessons and insights into the importance of physician empathy.
Equal Pay for Women Neurologists: Show Us the Money!
Dr. Tesha Monteith talks with Dr. Elizabeth Loder about her editorial on the gender pay gap in academic neurology and its impact on women neurologists as well as the field at large. Read the full article in Neurology.
COVID Vaccines and Neurology Immunotherapy; Health Disparities in Stroke Interventions
In the first part of the podcast, Dr. Justin Abbatemarco talks with Dr. Avi Nath, Director of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health, about COVID-19 vaccines and neurology immunotherapy (00:56). In the second segment, Dr. Andy Southerland discusses disparities in the utilization of stroke interventions with Dr. Adam de Havenon (18:18).
Small Fiber Neuropathy; Representation of Women in Stroke Clinical Trials
In the first part of the podcast, Dr. Stacey Clardy talks with Dr. Christopher Klein about small fiber neuropathy incidence, prevalence, longitudinal impairments, and disabilities (00:45). In the second segment, Dr. Amy Guzik discusses the representation of women in stroke clinical trials relative to the burden of disease in the population with Dr. Cheryl Carcel (16:12).
Peter Frampton on His Diagnosis of Myositis; Ethical Perspectives on Costly Drugs and Healthcare
In the first part of the podcast, Dr. Ted Burns interviews legendary musician Peter Frampton about his experience with inclusion body myositis and his storied career. For more with Peter Frampton, read the cover story in the October/November 2020 issue of Brain & Life, the AAN’s patient and caregiver magazine. In the second segment, Dr. Gordon Smith talks with Dr. Amy Tsou about the updated AAN Position Statement on ethical concerns raised by high drug costs.
Ethical Considerations in Dementia Diagnosis; Diagnosis of Mild Cognitive Impairment
In the first part of the podcast, Dr. Jeff Ratliff talks with Dr. Winston Chiong about the updated AAN Position Statement on Ethical Considerations in Dementia Diagnosis and Care. In the second segment, Dr. Gregg Day talks with Dr. Emily Edmonds about differing cognitive, biomarker, and neuropathologic trajectories in subtypes of mild cognitive impairment.
Out-of-Pocket Costs for MS Drugs; Part 4 of the Thunderclap Headache Series
In the first segment, Dr. Stacey Clardy talks with Dr. Daniel Hartung about whether closing the Part D coverage gap between 2010-2019 lowered patients’ out-of-pocket costs for multiple sclerosis drugs. In the second part of the podcast, Dr. Teshamae Monteith discusses sex, exercise, and other benign causes of thunderclap headache with Dr. Jonathan Smith in the final part of our four-part series on thunderclap headache.
Symptoms and Incidence of RCVS; Optimizing Stroke Prevention in Atrial Fibrillation
In the first segment, Will Rondeau discusses the symptoms, incidence, and resource utilization of reversible cerebrovascular vasoconstriction syndrome with Dr. Jessica Magid-Bernstein. In the second part of the podcast, Dr. Andy Southerland discusses the optimization of atrial fibrillation treatment and stroke prevention with Dr. Seemant Chaturvedi.
SPECIAL REPORT on Aducanumab Approval: Steve Pearson of ICER Discusses the Economic and Clinical Impact
Dr. Jason Crowell speaks with Dr. Steve Pearson, President of the Institute for Clinical and Economic Review, about the clinical and economic impact of aducanumab, a drug recently approved by the FDA for the treatment of Alzheimer disease.
Diagnostic Criteria for Traumatic Encephalopathy Syndrome; Trends in Neurology Drug Payments
In the first segment, Dr. Alex Menze talks to Dr. Robert Stern about developing NINDS consensus diagnostic criteria for traumatic encephalopathy syndrome. In the second part of the podcast, Dr. Jason Crowell speaks with Dr. Adam de Havenon about five-year cost trends and utilization of neurologist-prescribed drugs for Medicare Part D beneficiaries.
Financial COIs in Neurology Journals; Direct to Consumer Alzheimer's Testing
In the first segment, Dr. Stacey Clardy talks to Jade Smith about financial conflicts of interest of authors published in high-impact neurology journals. In the second part of the podcast, Dr. Jason Crowell speaks with Dr. Emily Largent about potential advancements and ethical challenges associated with blood testing for Alzheimer disease.
Neurology and COVID-19 in NYC; Immigrant Neurologists in the US
In the first segment, Dr. Jason Crowell speaks with Dr. Jennifer Frontera about neurology and COVID-19 in New York City. In the second part of the podcast, Dr. Jeffrey Ratliff talks with Dr. Abhimanyu Mahajan and Dr. Erica Schuyler about immigrant neurologists in the United States.
SPECIAL REPORT: Patients’ out of pocket costs in neurology
Dr. Stacey Clardy talks with Dr. Chloe Hill about increasing out-of-pocket costs for privately-insured patients to obtain neurologic diagnostic services.
Gender Representation in AAN Leadership, Publication, and Awards; Posterior Cortical Atrophy
In the first segment, Dr. Teshamae Monteith talks with Dr. Janis Miyasaki about gender representation in AAN leadership, publication, and awards. In the second part of the podcast, Dr. Jason Crowell speaks with journalist Jamie Talan about posterior cortical atrophy.
SPECIAL REPORT: Changing Neurology Education
Dr. ImaEbong and Dr. EseosaIghodaro discuss the changes in neurology education surrounding racial disparities.Read the associated article here.
Copaxone and drug pricing; Ultrasound-guided Lumbar Puncture
In the first segment, Dr. Jason Crowell talks with Eric Pachman about his report on copaxone and drug pricing. Next, Dr. Jeffrey Ratliff talks with Dr. Yi Li about herNeurology: Clinical Practicepaper discussing ultrasound-guided lumbar puncture.
Managing ischemic stroke, pt. 4; Cost of Surgery for Temporal Lobe Epilepsy in the US
Dr. Dan Ackerman and Dr. Andrew Southerland continue their discussion on managing ischemic stroke, in the 4th of a 5-part series. Dr. Jason Crowell talks with Dr. Lara Jehi about her paper discussing surgery costs in temporal lobe epilepsy.
Movement Disorder Emergencies Part 2; Patient and Public Involvement in Clinical Trials
In the first part of the podcast, Dr. Jeffrey Ratliff and Dr. Jason Crowell continue their discussion on movement disorder emergencies in the 2nd part of a 2-part dialogue. In the second segment, Dr. Stacey Clardy talks with Dr. Holly Hinson about herNeurology: ClinicalPracticeeditorial on patient and public involvement in clinical trials from the June 2020 issue.
Neurology on the Hill; Multiple hit theory of ALS
In the first segment, Dr. Jason Crowell speaks with Dr. Andrew Southerland about Neurology on the Hill. In the second part of the podcast, Dr. Matthew Harms talks with Dr. Steve Vucic about his paper on multiple hit theory of ALS.
SPECIAL REPORT: Joseph Kvedar (Pres.-elect of American Telemed) & Teshamae Monteith discuss value-based care in telemedicine, telestroke, & e-consults--the future is NOW
Dr. Teshamae Monteith talks with Dr. Joseph Kvedar about value-based care, e-consults, and telemedicine. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.
Generic glatiramer acetate reduces MS costs; Med adherence and out of pocket costs?
In the first segment, Dr. Jason Crowell talks with Dr. Daniel Hartung about his paper on the effect of generic glatiramer acetate on the reduction of MS costs. In the second part of the podcast, Dr. Jason Crowell speaks with Dr. Brian Callaghan about his paper—also from the March 31st issue ofNeurology—on the association between out-of-pocket costs and adherence to common neurologic medications.
Neurologists’ responsibility for social health; update on pediatric migraine
In the first segment, Dr. Jason Crowell talks with Dr. Joel Salinas about his editorial on neurologists’ duty to treat social ills. In the second part of the podcast, Dr. Teshamae Monteith talks with Dr. Andrew Hershey about his practice guideline update summary paper in Neurology® on pharmacologic treatment for pediatric migraine prevention.
Gender Equity in Neurology + Drug Pricing Update Part 1
In the first segment, Dr. Stacey Clardy talks with Dr. Julie Silver about her paper on understanding and addressing gender equity for women in neurology. In the second part of the podcast, Dr. Gordon Smith focuses his discussion with Dr. Steve Pearson on an update on drug pricing. Their previous discussion on drug pricing was featured in two parts on January 8th and January 15th, 2019.
A new paraneoplastic biomarker + Drug pricing controversies: “Evergreening” in pharma
In the first segment, Dr. Stacey Clardy talks with Dr. Anastasia Zekeridou about her paper on Phosphodiesterase 10A-IgG, a novel biomarker of paraneoplastic neurological autoimmunity. In the second part of the podcast, Dr. Jason Crowell focuses his discussion with Prof. Robin Feldman on “evergreening” and drug prices.
Out-of-pocket costs are on the rise for commonly prescribed neurologic medications
In the first segment, Dr. Jason Crowell talks with Dr. Brian Callaghan about rising out-of-pocket costs for commonly prescribed neurologic medications. In the second part of the podcast, Dr. Jeffrey Ratliff focuses his interview with Dr. Stefan Pulst on ataxias.
Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus
In the first segment, Dr. Lindsay Higdon talks with Dr. Ivan Sanchez Fernandez about his paper on the meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus. In the second part of the podcast, Dr. Stacey Clardy talks with Dr. Anthony Fauci about the measles outbreak of 2019. You can read the paper in NEJM.